Background: Optimal treatment to prevent or delay cognitive decline, mild cognitive
impairment (MCI), or dementia is uncertain. Purpose: To summarize current evidence on the …

The aetiology of cognitive impairment is multifactorial; however, drugs are an important
cause of delirium and dementia. Several factors may increase the risk of drug-induced …

Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

Objective: To examine whether baseline high blood pressure and antihypertensive
treatment predicts cognitive decline in elderly individuals. Methods: A longitudinal …

Many cardiovascular drugs have been implicated as causes of depression. With the
exception of beta-blockers, few have been studied in formal epidemiologic designs. I …

There is a lack of data about the practice effect and test-retest reliability (TRR) on many
attentional and executive tests in neuropsychology. In this study, 37 subjects aged 52 to 80 …

Forty‐two elderly patients (mean age, 66.2±5.1 yr) with hypertension, treated for an average
of 17.3 years (standard deviation, 10.3), and 42 control subjects (mean age, 66.5±4.8 yr) …

The aim of this study was to compare the effect of the beta-adrenergic blocker atenolol and
the Angiotensin II type 1 (AT1) receptor antagonist losartan on cognitive function in very …

Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

Management of hypertension in the elderly should take into account, in particular, the
possible negative impact of antihypertensive drugs on the patient's quality of life, the …